litlas
Log inCreate account

Craig L. Leonardi

Active 1993–2023

64
Papers
19,020
Citations
52
h-index
64
i10-index

Citations

Citations per year for Craig L. Leonardi1995: 2 citations1996: 1 citations1998: 5 citations1999: 1 citations2000: 1 citations2002: 1 citations2003: 1 citations2004: 15 citations2005: 37 citations2006: 49 citations2007: 82 citations2008: 97 citations2009: 157 citations2010: 129 citations2011: 172 citations2012: 199 citations2013: 234 citations2014: 234 citations2015: 239 citations2016: 222 citations2017: 268 citations2018: 247 citations2019: 645 citations2020: 709 citations2021: 615 citations2022: 460 citations2023: 391 citations2024: 564 citations2025: 270 citations2026: 1 citations1997: no citations, so this year is not shown2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,622 citing papers, 25.1% of this breakdownGermany: 493 citing papers, 7.6% of this breakdownUnited Kingdom: 472 citing papers, 7.3% of this breakdownCanada: 446 citing papers, 6.9% of this breakdownChina: 373 citing papers, 5.8% of this breakdownItaly: 347 citing papers, 5.4% of this breakdownFrance: 264 citing papers, 4.1% of this breakdownSpain: 223 citing papers, 3.5% of this breakdownJapan: 202 citing papers, 3.1% of this breakdownSwitzerland: 184 citing papers, 2.8% of this breakdownNetherlands: 167 citing papers, 2.6% of this breakdownDenmark: 153 citing papers, 2.4% of this breakdown
0%25.1%Other 23.4%

Institutions

Fields

  • Immunology and Microbiology58.2%
  • Medicine26.6%
  • Neuroscience6.9%
  • Biochemistry, Genetics and Molecular Biology5.6%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • Psychology0.5%
  • Other1.1%

Topics

  • Psoriasis: Treatment and Pathogenesis21.8%
  • Dermatology and Skin Diseases10.9%
  • Spondyloarthritis Studies and Treatments9.5%
  • Rheumatoid Arthritis Research and Therapies3.8%
  • Asthma and respiratory diseases2.8%
  • Tryptophan and brain disorders2.6%
  • Other48.6%

Coauthors

All papers

Open in search
  1. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

    Authors: Alan Menter, Bruce Strober, Daniel H. Kaplan, Darío Kivelevitch, Elizabeth Farley Prater, Benjamin K. Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena Rupani, Michael Siegel, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2019 cited by 924

  2. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

    Authors: Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi - New England Journal of Medicine 2016 cited by 838

  3. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

    Authors: Craig A. Elmets, Craig L. Leonardi, Dawn Marie R. Davis, Joel M. Gelfand, Jason Lichten, Nehal N. Mehta, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Darío Kivelevitch, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Henry W. Lim, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2019 cited by 486

  4. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

    Authors: Kim Papp, Kristian Reich, Craig L. Leonardi, Leon Kircik, Sergio Chimenti, Richard G. Langley, ChiaChi Hu, Randall M. Stevens, Robert M. Day, Kenneth B. Gordon, Neil J. Korman, C.E.M. Griffiths - Journal of the American Academy of Dermatology 2015 cited by 669

  5. Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

    Authors: Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily Wong, Reena Rupani, Darío Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2020 cited by 329

  6. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies

    Authors: Alan Menter, Joel M. Gelfand, Cody Connor, April W. Armstrong, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Darío Kivelevitch, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Robert S. Rahimi, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Elliot B. Tapper, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2020 cited by 331

  7. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

    Authors: Craig L. Leonardi, Alexa B. Kimball, Kim Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T. Dooley, Kenneth B. Gordon - The Lancet 2008 cited by 1,865

  8. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    Authors: Stephen K. Tyring, Alice B. Gottlieb, Kim Papp, Ken Gordon, Craig L. Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik, David Cella, Ranga Krishnan - The Lancet 2005 cited by 1,069

  9. Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

    Authors: Andrew Blauvelt, Craig L. Leonardi, Melinda Gooderham, Kim Papp, Sandra Philipp, Jashin J. Wu, Atsuyuki Igarashi, Mary Flack, Ziqian Geng, Tianshuang Wu, Anne Camez, David Williams, Richard G. Langley - JAMA Dermatology 2020 cited by 216

  10. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council

    Authors: Bruce Strober, Caitriona Ryan, Peter van de Kerkhof, Joelle van der Walt, Alexa B. Kimball, Jonathan Barker, Andrew Blauvelt, Marc Bourcier, André Vicente Esteves de Carvalho, Arnon D. Cohen, Peter Foley, Colby Evans, Paolo Gisondi, C.E.M. Griffiths, Mahira Hamdy El-Sayed, Cristina Eschevarria, A.Y. Finlay, Robert E. Kalb, Craig L. Leonardi, C. Lynde, Ruth Murphy, Masamoto Murakami, Yukari Okubo, Errol P. Prens, L. Puig, Marieke M.B. Seyger, Lone Skov, Tadashi Terui, Fernando Valenzuela, Nicole L. Ward, Jashin J. Wu, Min Zheng - Journal of the American Academy of Dermatology 2019 cited by 243

  11. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

    Authors: Andrew Blauvelt, Kim Papp, Alice B. Gottlieb, Abel Jarell, Kristian Reich, Catherine Maari, Kenneth B. Gordon, Laura K. Ferris, Richard G. Langley, Yayoi Tada, Renata Gontijo Lima, Hany Elmaraghy, Gaia Gallo, L. Renda, S‐M. Park, Russel Burge, Jerry Bagel, the IXORA‐R Study Group, Ronald Vender, Mark Lomaga, Isabelle Delorme, Chih-ho Hong, Richard L. Langley, Lorne Albrecht, Lyn Guenther, Catherine Maari, Kim Papp, Kamal Ohson, Kirk Barber, Charles Lynde, Aditya Gupta, Leslie Rosoph, Jean‐Sébastien Gauthier, Melinda Gooderham, Norman Wasel, Mani Raman, Marni Wiseman, David Greenstein, Abel Jarell, C. A. L. Moon, Lani Clark, S. Jazayeri, Michael Bukhalo, Angela Moore, Tiffani K. Hamilton, Aron Gewirtzman, Lydie Hazan, Jeffrey Crowley, Craig Teller, Matthew Zirwas, Stacy Smith, Mark Lee, Stephen K. Tyring, Patricia Lee, Sunil Dhawan, Craig L. Leonardi, Amarilis Perez‐De Jesus, Wendy McFalda, Ellen Frankel, Paul S. Yamauchi, Scott Fretzin, Rocco Serrao, Todd Schlesinger, Scott Gottlieb, Peter Jenkin, Rola Gharib, Steven A. Davis, Navid Nami, Zoe Diana Draelos, Lloyd Godwin, Cindy E. Owen, Megan N. Landis, William Abramovits, Samuel Sanchez‐Rivera, Abby Van Voorhees, David Fivenson, Francisco A. Kerdel, Seth Forman, Jeffrey S. Weinberg, José González-Chávez, Brent Boyce, Linda Stein‐Gold, Charles P. Hudson, Constance Brown, James Coggi, Christina Feser, Rion Forconi, Sandra Johnson, Mark McCune, Lawrence Green, Vandana Madkan, Dana Maxwell Shipp, Kenneth B. Gordon, Jill Waibel, Oscar Soto‐Raices, Jennifer Cather, Scott Miller, John P. Scott, Douglas Young, Jessica Kaffenberger and 42 more - British Journal of Dermatology 2019 cited by 172

  12. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis

    Authors: Robert E. Kalb, David Fiorentino, Mark Lebwohl, John Toole, Yves Poulin, Arnon D. Cohen, Kavitha Goyal, Steven Fakharzadeh, Stephen Calabro, Marc Chévrier, Wayne Langholff, Yin You, Craig L. Leonardi - JAMA Dermatology 2015 cited by 372

  13. A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis

    Authors: James G. Krueger, Mayte Suárez‐Fariñas, Inna Cueto, Artemis Khacherian, Robert Matheson, Lawrence Charles Parish, Craig L. Leonardi, Denise Shortino, Akanksha Gupta, Jonathan Haddad, George P. Vlasuk, Eric Jacobson - PLoS ONE 2015 cited by 103

  14. Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

    Authors: Kim Papp, Craig L. Leonardi, Alan Menter, Jean‐Paul Ortonne, James G. Krueger, Gregory Kricorian, Girish Aras, Juan Li, Chris B. Russell, Elizabeth H. Thompson, Scott Baumgartner - New England Journal of Medicine 2012 cited by 929

  15. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

    Authors: Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Alexa B. Kimball, Craig L. Leonardi, Richard G. Langley, Bruce Strober, Martin Kaul, Yihua Gu, Martin M. Okun, Kim Papp - Journal of the American Academy of Dermatology 2007 cited by 883

  16. Guidelines of care for the management of psoriasis and psoriatic arthritis

    Authors: Alan Menter, Neil J. Korman, Craig A. Elmets, Steven R. Feldman, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, John Koo, Mark Lebwohl, Craig L. Leonardi, Henry W. Lim, Abby S. Van Voorhees, Karl R. Beutner, Caitriona Ryan, Reva Bhushan - Journal of the American Academy of Dermatology 2011 cited by 454

  17. Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis

    Authors: Howard Sofen, Stacy Smith, Robert Matheson, Craig L. Leonardi, César A. Calderón, Carrie Brodmerkel, Katherine Li, Kim Campbell, Stanley J. Marciniak, Yasmine Wasfi, Yuhua Wang, Philippe Szapary, James G. Krueger - Journal of Allergy and Clinical Immunology 2014 cited by 302

  18. Etanercept as Monotherapy in Patients with Psoriasis

    Authors: Craig L. Leonardi, JEROLD L. POWERS, Robert Matheson, Bernard S. Goffe, Ralph Zitnik, Andrea Wang, Alice B. Gottlieb - New England Journal of Medicine 2003 cited by 1,181

  19. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy

    Authors: Craig A. Elmets, Henry W. Lim, Benjamin K. Stoff, Cody Connor, Kelly M. Cordoro, Mark Lebwohl, April W. Armstrong, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Darío Kivelevitch, Neil J. Korman, Daniela Kroshinsky, Craig L. Leonardi, Jason Lichten, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth A. Farley Prater, Reena Rupani, Michael Siegel, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2019 cited by 190

  20. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients

    Authors: Alan Menter, Kelly M. Cordoro, Dawn Marie R. Davis, Daniela Kroshinsky, Amy S. Paller, April W. Armstrong, Cody Connor, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Darío Kivelevitch, Neil J. Korman, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Sylvia L. Parra, Arun L. Pathy, Elizabeth A. Farley Prater, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2019 cited by 214

  21. Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis

    Authors: April W. Armstrong, Kyle Fahrbach, Craig L. Leonardi, Matthias Augustin, Binod Neupane, Paulina Kaźmierska, Marissa Betts, Andreas Freitag, Sandeep Kiri, V. Taieb, Mahmoud Slim, Natalie Núnez Gómez, Richard B. Warren - Dermatology and Therapy 2022 cited by 59

  22. Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

    Authors: Craig L. Leonardi, Robert Matheson, Claus Zachariae, Gregory S. Cameron, Linda Li, Emily Edson‐Heredia, Daniel Braun, Subhashis Banerjee - New England Journal of Medicine 2012 cited by 930

  23. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

    Authors: Kenneth B. Gordon, Richard G. Langley, Craig L. Leonardi, Darryl Toth, Alan Menter, Sewon Kang, Michael Heffernan, Bruce Miller, Regina Hamlin, Liberata Lim, Jianhua Zhong, Rebecca L. Hoffman, Martin M. Okun - Journal of the American Academy of Dermatology 2006 cited by 507

  24. From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis

    Authors: April W. Armstrong, Michael Siegel, Jerry Bagel, Erin Boh, Megan Buell, Kevin D. Cooper, Kristina Callis Duffin, Lawrence F. Eichenfield, Amit Garg, Joel M. Gelfand, Alice B. Gottlieb, John Koo, Neil J. Korman, Gerald G. Krueger, Mark Lebwohl, Craig L. Leonardi, Arthur M. Mandelin, Alan Menter, Joseph F. Merola, David M. Pariser, Ronald Prussick, Caitriona Ryan, Kara N. Shah, Jeffrey M Weinberg, Mary-Jane O. U. Williams, Jashin J. Wu, Paul S. Yamauchi, Abby S. Van Voorhees - Journal of the American Academy of Dermatology 2016 cited by 186